Cell membrane-coated nanoparticles for neurodegenerative disorders management

Area of Science:

• Nanomedicine
• Biomaterials Science
• Neuroscience

Background:

• Neurodegenerative disorders (ND) cause neuronal death, increasing global mortality and healthcare costs.
• Nanotechnology enables nanocarriers for targeted drug delivery, but brain barriers (BBB, BCFB) and efflux pumps impede transport.
• Biomimetic systems, particularly cell membrane-coated nanoparticles, show promise for overcoming these delivery challenges.

Purpose of the Study:

• To review recent advancements in cell membrane-coated nanoparticle drug delivery systems for neurodegenerative diseases.
• To highlight the application of these systems in managing conditions like Alzheimer's, Parkinson's, and stroke.
• To discuss challenges and future directions for clinical translation.

Main Methods:

• Comprehensive literature review of cell membrane-coated nanoparticles for neurodegenerative disease treatment.
• Analysis of strategies to overcome the Blood-Brain Barrier and Blood-Cerebrospinal Fluid Barrier.
• Evaluation of challenges including biosafety, toxicity, and regulatory hurdles.

Main Results:

• Cell membrane-coated nanoparticles demonstrate potential for enhanced drug delivery across brain barriers.
• These systems show promise for treating various neurodegenerative conditions, including Alzheimer's, Parkinson's, and stroke.
• Significant challenges remain regarding biosafety, toxicity, and clinical translation.

Conclusions:

• Cell membrane-coated nanoparticles represent a promising strategy for neurodegenerative disease management.
• Further research is crucial to address biosafety, toxicity, and regulatory issues for clinical application.
• Future directions include optimizing nanoparticle design and overcoming barriers for effective brain drug delivery.